Skip to content

Apotheek Popelier

Active
Private limited companyfounded 1990active for 35 yearsDorpsstraat 4a, 8200 Brugge, BelgiumKBO/BCE: BE 0441.997.821

Acts, filings and financial milestones

Deadline for the 2026 accounts: 30-04-2027
2026
02-04
NBB filing Annual accounts 2025 filedPDF
abbreviated format · 28 days before the deadline
2025
09-04
NBB filing Annual accounts 2024 filedPDF
abbreviated format · 21 days before the deadline
2024
03-04
NBB filing Annual accounts 2023 filedPDF
abbreviated format · 27 days before the deadline
2023
29-03
NBB filing Annual accounts 2022 filedPDF
abbreviated format · 32 days before the deadline
2022
30-09
Financial Highest result from 2019 to 2025net €83,177 ▲90.8%
The operating result of €87,902 and the net result of €83,177 are both a record.
16-03
NBB filing Annual accounts 2021 filedPDF
abbreviated format · 45 days before the deadline
14-03
Gazette deed Company renamed from Apotheek Depuydt to Apotheek Popelier
Resignations: De-puydt Tom (statutory director) and Van Der Linden Mady (director) · Appointments: Reba Pharma (director) and VEMAPHAR (director) · Permanent representatives: Popelier Bieke Joke and VERBEKE Koen Jozef22 points ▸
  • General meeting, 01-03-2022
  • Name change, Apotheek Popelier
  • Capital conversion, “statutair onbeschikbare eigen vermogensrekening” (deed in Dutch)
  • Reserve release, “opheffing, beschikbaar voor uitkering” (deed in Dutch)
  • Share issue, “bestaande inbreng, zelfde verhouding aan huidige aandeelhouders” (deed in Dutch)
  • Reba Pharma holds 150 shares
  • VEMAPHAR holds 150 shares
  • Amendment of the articles
  • Registered office clause, “Dorpsstraat 4A 8200 Brugge (Sint-Michiels)” (deed in Dutch)
  • Other provision, “verslag bestuurder artikel 5:101 WVV, voorzitter ontslagen van voorlezing” (deed in Dutch)
  • Other provision, “ontvangst verslag, elke aandeelhouder erkent afschrift ontvangen en kennis genomen” (deed in Dutch)
  • Purpose change
  • The act holds 10 more points.

Open the act in the Belgian Official Gazette

2021
30-09
Financial Back to profitnet €43,591
The net result is €43,591, after one loss-making year.
30-09
Financial Equity above €500,000equity €517,368 ▲9.2%
Equity rises from €473,777 to €517,368.
29-03
NBB filing Annual accounts 2020 filedPDF
abbreviated format · 32 days before the deadline
2020
30-09
Financial Weakest financial yearnet -€1,080
The net result drops to -€1,080, the lowest from 2019 to 2025. It recovers the following year.
25-03
NBB filing Annual accounts 2019 filedPDF
abbreviated format · 36 days before the deadline
Show earlier events
2019
03-04
NBB filing Annual accounts 2018 filedPDF
abbreviated format · 27 days before the deadline
2018
09-04
NBB filing Annual accounts 2017 filedPDF
abbreviated format · 21 days before the deadline
2017
21-04
NBB filing Annual accounts 2016 filedPDF
abbreviated format · 9 days before the deadline
1990
23-11
Gazette deed Incorporation
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.

Sources:Publications in the Belgian Official GazetteFilings with the National Bank

History

Apotheek Popelier was incorporated on 9 November 1990.1 Since 2022 the company has been called Apotheek Popelier.2 Total assets fell from €1.0m in 2019 to €784,245 in 2025 and headcount from 0.7 full-time equivalents in 2019 to 1 in 2023.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 14-03-2022
  3. 3National Bank, annual accounts 2019, 2023 and 2025

Next steps